BeiGene is a global oncology company focused on developing and commercialising cancer medicines. The company has a workforce of approximately 12,000 people, including over 1,200 research team members, and maintains a presence across six continents with more than 45 office locations worldwide. Its stated mission, operating under the BeOne Medicines identity, is to build a leading oncology company through scientific excellence and rapid development timelines.
The company's pipeline spans several technical domains, including oncology, haematology, solid tumours, protein degradation via CDACs, and antibody-drug conjugates. BeiGene has initiated more than 175 clinical trials, enrolling over 30,000 patients across 45 or more countries and regions. Three of its internally developed medicines have received regulatory approval in upwards of 75 countries.
BeiGene describes its workplace culture around five principles: Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit. The company characterises its internal environment as non-hierarchical and oriented toward challenging the status quo.
